Canandaigua National Bank & Trust Co. Buys Shares of 3,820 HCA Healthcare, Inc. (NYSE:HCA)

Canandaigua National Bank & Trust Co. acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 3,820 shares of the company's stock, valued at approximately $1,320,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Canandaigua National Trust Co of Florida bought a new stake in HCA Healthcare during the 1st quarter valued at approximately $660,000. IRON Financial LLC purchased a new position in HCA Healthcare during the 1st quarter valued at approximately $217,000. Amalgamated Bank raised its holdings in shares of HCA Healthcare by 1.0% during the 1st quarter. Amalgamated Bank now owns 36,694 shares of the company's stock worth $12,680,000 after acquiring an additional 346 shares in the last quarter. TBH Global Asset Management LLC grew its holdings in shares of HCA Healthcare by 8.2% in the first quarter. TBH Global Asset Management LLC now owns 7,663 shares of the company's stock valued at $2,648,000 after purchasing an additional 582 shares in the last quarter. Finally, Vista Investment Partners II LLC lifted its position in HCA Healthcare by 24.0% during the first quarter. Vista Investment Partners II LLC now owns 5,112 shares of the company's stock valued at $1,766,000 after purchasing an additional 989 shares during the last quarter. Institutional investors own 62.73% of the company's stock.

Insider Activity

In related news, COO Jon M. Foster sold 15,698 shares of the firm's stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the sale, the chief operating officer owned 12,646 shares of the company's stock, valued at $4,670,420.72. This trade represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 1.30% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the stock. Royal Bank Of Canada restated an "outperform" rating and set a $404.00 target price (up from $376.00) on shares of HCA Healthcare in a research report on Monday, June 23rd. Morgan Stanley set a $410.00 price objective on HCA Healthcare and gave the company an "equal weight" rating in a research note on Monday, June 9th. Wall Street Zen lowered HCA Healthcare from a "buy" rating to a "hold" rating in a report on Friday, June 27th. Barclays set a $416.00 price objective on shares of HCA Healthcare and gave the company an "overweight" rating in a research report on Monday, June 2nd. Finally, Baird R W downgraded shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Eight research analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $395.71.

HCA Healthcare Trading Down 1.4%

NYSE:HCA traded down $5.20 during midday trading on Friday, hitting $372.84. The stock had a trading volume of 943,125 shares, compared to its average volume of 1,461,363. The company has a quick ratio of 1.06, a current ratio of 1.19 and a debt-to-equity ratio of 69.07. The stock has a 50-day moving average of $370.64 and a 200 day moving average of $338.65. The company has a market capitalization of $89.69 billion, a price-to-earnings ratio of 16.58, a PEG ratio of 1.31 and a beta of 1.47. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, beating the consensus estimate of $5.75 by $0.70. The firm had revenue of $18.32 billion during the quarter, compared to the consensus estimate of $18.26 billion. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The firm's quarterly revenue was up 5.7% on a year-over-year basis. During the same period in the previous year, the company posted $5.36 earnings per share. As a group, sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, June 30th. Shareholders of record on Monday, June 16th were issued a dividend of $0.72 per share. The ex-dividend date of this dividend was Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.77%. HCA Healthcare's dividend payout ratio is currently 12.81%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.